leadf
logo-loader
viewBioSig Technologies, Inc.

BioSig teams up with Sorrento Therapeutics to fight the coronavirus with a combination treatment

BioSig Technologies Inc (NASDAQ:BSGM) CEO Kenneth Londoner tells Proactive the group's subsidiary ViralClear Pharmaceuticals, Inc is teaming up with Sorrento Therapeutics, Inc. (NASDAQ: SRNE) to advance the fight against the coronavirus. Londoner says the two biotechs will look at the effective doses between the two drugs already in human clinical trials and will try to specifically demonstrate that the combined benefits in strengthening and accelerating viral clearance exceed what each drug could deliver by itself.

Quick facts: BioSig Technologies, Inc.

Price: 3.16 USD

NASDAQ:BSGM
Market: NASDAQ
Market Cap: $94.18 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of BioSig Technologies, Inc. named herein, including the promotion by the Company of BioSig Technologies, Inc. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

BioSig Technologies forms Scientific Advisory Board by adding industry veterans

BioSig Technologies Inc (NASDAQ:BSGM) CEO Kenneth Londoner tells Proactive its subsidiary ViralClear Pharmaceuticals Inc has formed its Scientific Advisory Board with two industry veterans experienced as both regulators and corporate executives. Londoner adds what's more, the group adopted a...

on 07/21/2020

2 min read